|
A hereditary blood disease
Thalassemia (also called
Mediterranean anemia) is a
hereditary blood disease, that
affects most commonly people of
Mediterranean or Asian ancestry.
Although thalassemia in its
severe form (thalassemia major)
can lead to severe symptoms that
require lifelong treatment,
patients affected by mild
thalassemia (thalassemia minor)
can live normal lives without
treatment, and even become sport
champions.
This is well shown by Pete
Sampras, the U.S. tennis player
of Greek origin who, in spite of
his disease, was able to win a
record of 14 Grand Slam men’s
singles titles during his
15-year tennis career.
Thalassemia is a blood disease
characterized by a total or
partial deficiency of
haemoglobin, the blood protein
found in the red cells that is
responsible for transporting
oxygen to the various tissues.
This condition can lead to
anemia and associated symptoms
of fatigue, weakness, short
breathing, paleness or jaundice
(a yellowish colour of the skin
or eyes), slow growth, facial
bone deformities and dark urine.
However these symptoms are
usually present in patients
affected by the severe form of
thalassemia, while those
affected by the mild form (such
as Pete Sampras) often suffer no
symptoms or experience only mild
ones.
The cause of thalassemia has
been well established and relies
upon a genetic defect in the
synthesis of haemoglobin.
Several genes (inherited from
both parents) are involved in
the synthesis of haemoglobin, so
the severity of thalassemia
depends upon how many of these
genes are defective.
Severity of symptoms
In general terms we can say that
the greater is the number of
defective genes, the more severe
are the symptoms (such as
fatigue, weakness, pale or
yellowish skin) and
complications (such as bone
deformities, slow growth, spleen
enlargement and heart problems).
The treatment of thalassemia
depends on the severity of the
disease. People who are affected
by the mild form can live normal
lives even without treatment,
although they can occasionally
require blood transfusions,
especially after surgery, giving
birth or when they develop an
infection.
On the contrary, moderate or
severe thalassemia usually
requires frequent blood
transfusions, which are not
devoid of risk.
In fact, besides the risk of
developing blood-borne
infections, patients treated
with repeated blood transfusions
can develop a medical condition
known as iron overload (due to
excess iron), which in turn can
lead to heart and liver
problems.
This is the reason why patients
who receive repeated blood
transfusions are often treated
also with specific medications
intended to prevent iron
overload. For patients with
extremely severe thalassemia, a
bone marrow transplant may be
needed, although this surgical
procedure is rarely performed
due to its risk.
Thalassemia and remedies
Lifestyle remedies are important
as well. Diet should be well
balanced, rich in nutritious
energy-dense foods and possibly
supplemented (according to the
doctor’s advice) with folic acid
to help make new red cells, as
well as zinc, calcium and
vitamin D to help bones stay
healthy.
However, it is important to
remember that, to avoid iron
overload, vitamins and other
supplements should not contain
iron.
Because of their need to receive
occasional or repeated
transfusions, patients affected
by thalassemia should have
themselves be covered by an
appropriate health insurance
plans before the condition
occurs.
International
Health Cover is an
International
Health Insurance
advisor. We provide full
advice over a full range of
International Medical Insurance
plans. Our quotation and advice
are free.
Please request a
free
quote.
You may also
contact one
of our highly
trained advisor.
*Always seek professional
medical advise from a qualified
doctor before undergoing any
treatment.
|